Skip to main content
. 2016 Dec 30;11(12):e0169044. doi: 10.1371/journal.pone.0169044

Fig 4. VGCC contribution to SK.

Fig 4

(A) Application of 10 μM isradipine (orange) to inhibit CaV1 channels did not reduce total SK charge (n = 8, Wilcoxon signed rank test, p = 0.3828), while inhibiting CaV3 channels with 10 μM mibefradil (blue) inhibited roughly half the charge (n = 8, Wilcoxon signed rank test, p = 0.0078). (B) 5 μM baclofen (green) application did not inhibit T-type calcium current (n = 12, Wilcoxon signed rank test, p = 0.1099).